According to our (Global Info Research) latest study, the global Automated Hematology Analyzer market size was valued at US$ 1388 million in 2025 and is forecast to a readjusted size of US$ 1855 million by 2032 with a CAGR of 4.2% during review period.
An Automated Hematology Analyzer is an in-vitro diagnostic instrument designed to automatically load, mix, test, classify, control quality, and report results for human whole blood samples. It primarily measures red blood cells, white blood cells, platelets, hemoglobin, and related derived parameters, while providing auxiliary flags for abnormal cells, inflammatory responses, anemia status, platelet abnormalities, and risks associated with hematological disorders. The instrument typically integrates precision fluidics, optical detection, impedance detection, fluorescence staining, automatic sample identification, barcode management, data processing software, quality-control modules, and laboratory information system interfaces. It supports three-part and five-part differentiation, reticulocyte testing, auto-review rules, and laboratory automation connectivity. Its core value lies in replacing repetitive manual work with automation, improving result consistency through standardization, and enhancing abnormal sample recognition through intelligent workflows, making it a foundational instrument for high-throughput, low-error, and digital laboratory operations.In 2025, global Automated Hematology Analyzer production reached approximately 111.93 k units and price is about 12.05 k USD/Unit.The average gross profit margin of this product is 45%.
Automated hematology analyzers sit at the center of clinical laboratory automation upgrades. Market opportunities are driven by rising healthcare service volume, improved laboratory productivity, medical equipment renewal policies, county-level healthcare capacity building, and high-end substitution by domestic brands. Complete blood count testing is a foundational item across hospital outpatient, emergency, inpatient, preoperative assessment, infection management, chronic disease monitoring, oncology follow-up, and health examination scenarios, characterized by large sample volumes, high testing frequency, and strong demand for timely results. Through automated sample loading, barcode recognition, automatic mixing, automatic testing, intelligent validation, and result connectivity, automated hematology analyzers significantly improve laboratory throughput and result consistency. For manufacturers, the product is not merely an equipment sales entry point, but a long-term customer operation platform covering reagent matching, quality control, maintenance, informatics, and total laboratory solutions.Competition in the automated hematology analyzer industry is shifting from standalone parameter competition to an integrated contest of instrument performance, automation capability, software algorithms, and service systems. Premium customers increasingly require analytical accuracy, abnormal cell flagging, low platelet recognition, anti-interference capability, auto-review rules, automation-line compatibility, and long-term operational stability. Manufacturers must continue investing in core optics, precision fluidics, sensors, algorithms, and quality systems. Although demand in primary healthcare institutions is broad, budget constraints and price sensitivity remain significant, while procurement cycles are influenced by fiscal spending, tender policies, and replacement schedules. Imported brands still maintain technical recognition and brand inertia in high-end hospitals, requiring domestic companies to keep advancing through reliability, clinical recognition, and system-solution capabilities.Downstream demand is moving from “being able to test” toward “high efficiency, low labor dependence, connectivity, traceability, and intelligent validation.” Large hospitals focus on high-throughput testing, automated rechecks, sample pre-processing, digital morphology linkage, and multi-system integration, aiming to reduce manual review pressure and shorten report turnaround time. County hospitals and regional testing centers emphasize equipment stability, ease of operation, remote quality control, and regional sample collaboration. Primary healthcare institutions need automated instruments with simple maintenance, stable results, and low training costs. Independent clinical laboratories pursue batch-processing capacity, continuous operation, and optimized unit testing cost. In the future, automated hematology analyzers will become core nodes in laboratory automation lines and regional diagnostic networks.
This report is a detailed and comprehensive analysis for global Automated Hematology Analyzer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automated Hematology Analyzer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2021-2032
Global Automated Hematology Analyzer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2021-2032
Global Automated Hematology Analyzer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2021-2032
Global Automated Hematology Analyzer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automated Hematology Analyzer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automated Hematology Analyzer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Danaher, Abbott Laboratories, Siemens Healthineers, HORIBA, Boule Diagnostics AB, Nihon Kohden, BioSystems, Diatron, Mindray Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Automated Hematology Analyzer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Three-part Differential
Five-part Differential
Market segment by Application Scenario
Clinical
Screening
Research
Other
Market segment by System Form
Benchtop
Floor-standing
Market segment by Application
Public Hospitals
Third-party Independent Laboratory
Other
Major players covered
Sysmex Corporation
Danaher
Abbott Laboratories
Siemens Healthineers
HORIBA
Boule Diagnostics AB
Nihon Kohden
BioSystems
Diatron
Mindray Medical
DYMIND
Urit Medical
Zybio
Dirui Medical
Maccura
Sinnowa
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automated Hematology Analyzer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Automated Hematology Analyzer, with price, sales quantity, revenue, and global market share of Automated Hematology Analyzer from 2021 to 2026.
Chapter 3, the Automated Hematology Analyzer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automated Hematology Analyzer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Automated Hematology Analyzer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Automated Hematology Analyzer.
Chapter 14 and 15, to describe Automated Hematology Analyzer sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Automated Hematology Analyzer. Industry analysis & Market Report on Automated Hematology Analyzer is a syndicated market report, published as Global Automated Hematology Analyzer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Automated Hematology Analyzer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.